In the closing days of June 2026, the industry's two biggest trade groups — AHIP, representing most national insurers, and the Blue Cross Blue Shield Association, whose 33 member plans cover roughly a third of insured Americans — announced new prior authorization commitments, per the American Medical Association's coverage, adding volume to a reform wave that began with insurers' 2023 pledge to CMS and accelerated when major insurers' voluntary reforms took effect January 1, 2026.
This article publishes information, not insurance or medical advice. Trade-group pledges bind member plans unevenly; your plan's actual prior authorization list is the document that governs your care.
What did the trade groups announce?
Per the AMA's reporting on the late-June announcements, the plans committed to shrinking the lists of services requiring prior authorization, honoring authorization decisions when a patient changes plans during a treatment course, and expanding electronic decision channels. They follow the six-reform industry pledge that HHS and CMS secured from insurers earlier in the decade and the CMS-0057-F requirements that took effect January 1, 2026.
Related stories: CMS-0057-F Kicked In January 1: Prior Authorization Records Go Electronic · CMS Launched an Electronic Prior Authorization Push on May 6.
Why does the shrinkage of prior auth lists matter?
The list is the lever. A 2026 KFF analysis found insurers denied at least 1 in 8 standard prior authorization requests across MA, Medicaid managed care, and marketplace plans, with wide variation between insurers — evidence that denial patterns reflect plan policy, not just clinical judgment. Removing low-risk services from the list eliminates the delay before it happens, which is faster than any appeals process.
What should patients do with these pledges?
Treat them as leverage, not law. Ask your plan, in writing, which services it removed from prior authorization for 2026, and whether it will transfer an active authorization if you switch plans mid-treatment — a commitment the trade groups say is coming. If a denial arrives for a service your plan has publicly de-listed, cite the plan's own policy in your appeal; internal consistency is a powerful argument at the external review stage.
What to watch next
The test is the 2027 evidence of coverage documents, published in the fall: do the lists actually shrink, and do denial rates fall? State regulators are watching too — 31 states passed prior authorization laws in 2025, per KQED reporting, so federal voluntarism now competes with state mandates that have teeth.
For more context, read CMS Launched an Electronic Prior Authorization Push on May 6.
For more context, read cms-0057-f prior authorization rule.
For more context, read medpac june 2026 report.